Cargando…
Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment
Systemic delivery of oncolytic viruses has been widely regarded as an impractical option for antitumor treatment. Here, we selected two target genes as leading components, and significant therapeutic effects were obtained by simultaneously reducing the expression of transforming growth factor β 1 (T...
Autores principales: | Choi, Soojin, Hong, Jeong A., Choi, Hye Jin, Song, Jae J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539630/ https://www.ncbi.nlm.nih.gov/pubmed/36247810 http://dx.doi.org/10.1016/j.omto.2022.09.004 |
Ejemplares similares
-
Expression and release of glucose-regulated protein-78 (GRP78) in multiple myeloma
por: Steiner, Normann, et al.
Publicado: (2017) -
GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021) -
The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection
por: Carlos, Anthony J., et al.
Publicado: (2021) -
Mitochondrial metabolic regulation by GRP78
por: Prasad, Manoj, et al.
Publicado: (2017) -
Differential requirement of GRP94 and GRP78 in mammary gland development
por: Zhu, Genyuan, et al.
Publicado: (2014)